Shandong Lukang Pharmaceutical Co.,Ltd. (600789.SS)
CNY 8.56
(0.59%)
CNY 8.56
(0.59%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 6.14 Billion | 5.62 Billion | 4.89 Billion | 4.2 Billion | 3.73 Billion | 3.32 Billion |
| Cost of Revenue | 4.68 Billion | 4.37 Billion | 3.74 Billion | 3.22 Billion | 2.67 Billion | 2.29 Billion |
| Gross Profit | 1.46 Billion | 1.24 Billion | 1.14 Billion | 980.13 Million | 1.05 Billion | 1.03 Billion |
| Operating Expenses | 1.18 Billion | 954.39 Million | 912.44 Million | 820.83 Million | 834.02 Million | 747.84 Million |
| Selling, General and Administrative Expenses | 747.55 Million | 519.21 Million | 533.74 Million | 506.87 Million | 585.61 Million | 522.53 Million |
| Research and Development Expenses | 345.78 Million | 275.83 Million | 254.3 Million | 192.63 Million | 140.84 Million | 125.61 Million |
| Other Expenses | 31.66 Million | 159.34 Million | 124.39 Million | 121.33 Million | 107.56 Million | 5.23 Million |
| Cost and Expenses | 5.81 Billion | 5.32 Billion | 4.65 Billion | 4.04 Billion | 3.51 Billion | 3.04 Billion |
| Operating Income | 277.16 Million | 307.66 Million | 226.9 Million | 154.77 Million | 257.5 Million | 187.07 Million |
| Interest Expense | 79.17 Million | 98.04 Million | 65.12 Million | 63.34 Million | 56.78 Million | 43.72 Million |
| Income Tax Expense | 16.18 Million | 6.98 Million | 22.77 Million | 28.67 Million | 20.03 Million | 18.88 Million |
| Earnings before Tax | 272.97 Million | 150.09 Million | 106.25 Million | 262.16 Million | 148.81 Million | 192.31 Million |
| Net Income | 246.17 Million | 138.01 Million | 89.09 Million | 227.87 Million | 121.25 Million | 161.38 Million |
| Earnings Per Share Basic | 0.27 | 0.16 | 0.10 | 0.26 | 0.14 | 0.19 |
| Earnings Per Share Diluted | 0.27 | 0.15 | 0.10 | 0.25 | 0.14 | 0.19 |
| Weighted Average Shares Outstanding | 896.03 Million | 886.88 Million | 880.59 Million | 880.22 Million | 880.22 Million | 849.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 896.03 Million | 920.08 Million | 880.59 Million | 911.5 Million | 880.22 Million | 849.4 Million |
| Gross Margin | 0.24 | 0.22 | 0.23 | 0.23 | 0.28 | 0.31 |
| EBIT Margin | 0.12 | 0.12 | 0.11 | 0.09 | 0.12 | 0.14 |
| Profit Margin | 0.04 | 0.02 | 0.02 | 0.05 | 0.03 | 0.05 |
| EBITDA | 741.88 Million | 611.59 Million | 486.16 Million | 570.67 Million | 392.53 Million | 393.69 Million |
| Earnings Before Tax Margin | 0.05 | 0.05 | 0.05 | 0.04 | 0.07 | 0.06 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 1.38 Billion | 1.46 Billion | 1.78 Billion | 6.09 Billion | 1.4 Billion | 1.54 Billion |
| Cost of Revenue | 1.1 Billion | 1.2 Billion | 1.36 Billion | 4.72 Billion | 1.02 Billion | 1.13 Billion |
| Gross Profit | 282.23 Million | 265.97 Million | 415.97 Million | 1.36 Billion | 378.29 Million | 406.02 Million |
| Operating Expenses | 218.87 Million | 230.48 Million | 343.3 Million | 1.09 Billion | 331.93 Million | 324.73 Million |
| Selling, General and Administrative Expenses | 336.45 Million | 155.54 Million | 264.44 Million | - | 183.82 Million | 310.06 Million |
| Research and Development Expenses | 64.27 Million | 68.27 Million | 80.65 Million | - | 105.43 Million | 82.71 Million |
| Other Expenses | -181.85 Million | -6.65 Million | 1.79 Million | -36.32 Million | -42.67 Million | 324.56 Thousand |
| Cost and Expenses | 1.32 Billion | 1.43 Billion | 1.71 Billion | 5.81 Billion | 1.35 Billion | 1.46 Billion |
| Operating Income | 52.37 Million | 35.49 Million | 72.66 Million | 277.16 Million | 46.36 Million | 72.06 Million |
| Interest Expense | 20.66 Million | 17.45 Million | 19.03 Million | 79.17 Million | 24.02 Million | 21.29 Million |
| Income Tax Expense | 1.2 Million | 4.25 Million | 9.95 Million | 16.18 Million | -5.7 Million | 8.16 Million |
| Earnings before Tax | 51.41 Million | 242.1 Million | 82.69 Million | 280.14 Million | 54.51 Million | 72.38 Million |
| Net Income | 47.09 Million | 232.65 Million | 67.3 Million | 246.17 Million | 53.62 Million | 61.17 Million |
| Earnings Per Share Basic | 0.05 | 0.26 | 0.08 | - | 0.06 | 0.07 |
| Earnings Per Share Diluted | 0.05 | 0.26 | 0.08 | - | 0.06 | 0.07 |
| Weighted Average Shares Outstanding | 898.66 Million | 897.16 Million | 896.05 Million | 896.03 Million | 896.03 Million | 890.92 Million |
| Weighted Average Shares Outstanding (Diluted) | 898.66 Million | 897.16 Million | 896.05 Million | 896.03 Million | 896.03 Million | 890.92 Million |
| Gross Margin | 0.20 | 0.18 | 0.23 | 0.22 | 0.27 | 0.26 |
| EBIT Margin | 0.05 | 0.09 | 0.06 | - | 0.10 | 0.05 |
| Profit Margin | 0.03 | 0.16 | 0.04 | 0.04 | 0.04 | 0.04 |
| EBITDA | 72.07 Million | 131.91 Million | 105.24 Million | - | 139.87 Million | 71.21 Million |
| Earnings Before Tax Margin | 0.04 | 0.02 | 0.04 | 0.05 | 0.03 | 0.05 |
1171
688513
SBW
5162
0F2S
200541